返回 Agenda
Clinically Meaningful: How is it Different from Statistical Significance?
Session Chair(s)
Anil Bhojwani, MPHARM
Sr. Manager (Sr Group Lead), Global Clinical Communication
Eli Lilly and Company, India
An interactive session to compare clinically meaningful results with statistical significance results, share tips and techniques to interpret clinically significant results, followed by live examples and demonstration of interpretation of results.
Learning Objective : Discuss how does clinically significant data differs from statistically significant data; Analyze clinically relevant changes in outcomes by several similar terms including “minimal clinically important differences (MCID)”, “clinically meaningful differences (CMD)”, and “minimally important changes (MIC)”.
Speaker(s)
Making Sense of it All: P-Values Versus Clinical Relevance
Stephen Corson, PHD
Phastar, United Kingdom
Associate Director, Statistics and Technical Solutions